| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.03 |